Viewing Study NCT00841308


Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2026-01-01 @ 1:02 AM
Study NCT ID: NCT00841308
Status: UNKNOWN
Last Update Posted: 2012-05-25
First Post: 2009-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Home Blood Pressure in Hypertension Management
Sponsor: University of Athens
Organization:

Study Overview

Official Title: Antihypertensive Drug Treatment Decisions Based on Home Blood Pressure Monitoring
Status: UNKNOWN
Status Verified Date: 2012-05
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: HBP10
Brief Summary: This is a prospective randomized study with two arms: the Conventional and Ambulatory blood pressure monitoring arm and the Home blood pressure monitoring arm. The study will include both previously treated and untreated individuals.

Before randomization and in the end of the study, measurements will be performed using all three blood pressure monitoring methods (Conventional, Ambulatory and Home) as well as assessment of target organ damage (microalbuminuria, electrocardiogram, echocardiogram, carotid-femoral pulse wave velocity and central blood pressure).

The participants will be randomized into one of the two arms. Diagnosis and titration will be decided according to either Conventional and Ambulatory blood pressure measurements or according to Home blood pressure measurements. Subjects will be followed up for one year.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: